Transformation of MALT lymphoma to pure plasma cell histology: possible association with anti-CD20 antibody treatment

Isr Med Assoc J. 2009 Nov;11(11):703-4.

Authors

Noa Klein¹, Avishay Elis, Judith Radnay, Ruth Zemer, Ami Klein, Michael Lishner

Affiliation

¹ Department of Internal Medicine, Meir Medical Center, Kfar Saba, Israel.

PMID: 20108563

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal / therapeutic use*
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents / therapeutic use*
Cell Transformation, Neoplastic*
Humans
Lung Neoplasms / drug therapy
Lung Neoplasms / immunology
Lung Neoplasms / pathology*
Lymphoma, B-Cell, Marginal Zone / drug therapy
Lymphoma, B-Cell, Marginal Zone / immunology
Lymphoma, B-Cell, Marginal Zone / pathology*
Male
Middle Aged
Neoplasms, Plasma Cell / pathology*
Pleural Effusion, Malignant / pathology*
Rituximab

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents
Rituximab